November 16, 2018 3:18 AM ET

Biotechnology

Company Overview of NOD Pharmaceuticals, Inc.

Company Overview

NOD Pharmaceuticals, Inc., a development stage biotech and drug delivery company, together with its subsidiary, Biolaxy, develops oral formulations for biopharmaceuticals. It focuses on developing oral formulations for insulin, exenatide, interferon, human growth hormone, and more. The company’s products in pipeline include Nodlin, an oral insulin formulation that is in Phase 1 trial for basal insulin supplementation; and Nodexen, an oral exenatide for diabetic treatment. NOD Pharmaceuticals, Inc. was founded in 2005 and is based in San Diego, California. It has a subsidiary location in China.

9924 Mesa Rim Road

San Diego, CA 92121

United States

Founded in 2005

Phone:

858-206-0883

Fax:

518-690-8818

Key Executives for NOD Pharmaceuticals, Inc.

Co-Founder, Chief Executive Officer and Director
Compensation as of Fiscal Year 2018.

Similar Private Companies By Industry

Company Name Region
1910 Genetics Inc. United States
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
2D Genomics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NOD Pharmaceuticals, Inc., please visit www.nodpharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.